Equity-Based Compensation |
10.Equity-Based Compensation Omnibus Equity Plan and Employee Stock Purchase Plan In connection with the closing of the IPO, the Company adopted the Omnibus Equity Plan and ESPP. Under the Omnibus Equity Plan, incentive awards may be granted to employees, directors, and consultants of the Company. The Company initially reserved 3,719,000 shares of common stock for future issuance under the Omnibus Equity Plan, including any shares subject to awards under the 2021 Equity Incentive Plan (the “2021 Equity Plan”) that are forfeited or lapse unexercised. The number of shares reserved for issuance under the Omnibus Equity Plan will automatically increase on the first day of each fiscal year, starting in 2022 and continuing through 2031, by a number of shares equal to (a) 4% of the total number of shares of the Company’s common stock outstanding on the last day of the immediately preceding fiscal year or (b) such smaller number of shares as determined by the Company’s Board of Directors. Under the ESPP, the Company initially reserved 743,803 shares of common stock for future issuance. The number of shares of common stock reserved for issuance will automatically increase on the first day of each fiscal year beginning in 2022 and ending in 2031, by a number of shares equal to (a) 1% of the total number of shares of the Company’s common stock outstanding on the last day of the immediately preceding fiscal year or (b) such smaller number of shares as determined by the Company’s Board of Directors. On April 1, 2022, the Company filed a Registration Statement on Form S-8 with the SEC for the purpose of registering an additional 5,921,056 shares of the Company’s common stock, inclusive of 1,536,845 and 384,211 shares associated with automatic increases that occurred on January 3, 2022 under the Omnibus Equity Plan and ESPP, respectively. This registration also included 3,200,000 and 800,000 shares for the Omnibus Equity Plan and the ESPP, respectively, representing two years’ worth of estimated future automatic increases in availability for these plans. On March 8, 2023, the Company’s Board of Directors approved the Fiscal 2023 Bonus Plan (“2023 Bonus Plan”) that granted RSUs to eligible employees on April 1, 2024, instead of the typical cash bonus. For the thirteen weeks ended March 31, 2024, equity-based compensation expense for the 2023 Bonus Plan was reversed by $0.1 million to reflect the actual bonus distribution. As of March 31, 2024, the unrecognized equity-based compensation expense for 2023 Bonus Plan was immaterial. On April 1, 2024, 95,912 fully vested RSUs were awarded to eligible employees under the 2023 Bonus Plan. On June 29, 2023, the Company filed a Registration Statement on Form S-8 with the SEC for the purpose of registering an additional 2,000,000 shares of the Company's common stock under the Omnibus Equity Plan corresponding to the increase in shares approved by stockholders at the 2023 annual meeting of stockholders. As of March 31, 2024, the Company had 1,704,230 and 1,368,288 shares available for issuance under the Omnibus Equity Plan and ESPP, respectively. The compensation committee of the Company’s Board of Directors (the “Compensation Committee”) administers the Omnibus Equity Plan and determines to whom awards will be granted, the exercise price of any options, the vesting schedule and the other terms and conditions of the awards granted under the Omnibus Equity Plan. The Compensation Committee may or may not issue the full number of shares that are reserved for issuance. The Company’s initial ESPP offering period commenced on August 26, 2022. The ESPP consists of consecutive, overlapping 12-month offering periods that begin on each August 26 and February 26 during the term of the ESPP, and end on each August 25 and February 25 occurring 12 months later, as applicable. Each offering period is comprised of two consecutive six-month purchase periods that begin on each August 26 and February 26 within each offering period and end on each February 25 and August 25, respectively, thereafter. The duration and timing of offering periods and purchase periods may be changed by the Company’s Board of Directors or Compensation Committee at any time. The ESPP allows participants to purchase shares of the Company’s common stock at a 15 percent discount from the lower of the Company’s stock price on (i) the first day of the offering period or on (ii) the last day of the purchase period and includes a rollover mechanism for the purchase price if the stock price on the purchase date is less than the stock price on the offering date. The ESPP also allows participants to reduce their percentage election once during the offering period, but they cannot increase their election until the next offering period. The Company recognizes equity-based compensation expense related to shares issued pursuant to the ESPP on a graded vesting approach over each offering period. For the thirteen weeks ended March 31, 2024 and April 2, 2023, equity-based compensation expense related to our ESPP was immaterial and $0.1 million, respectively. During the thirteen weeks ended March 31, 2024 and April 2, 2023, the Company issued 52,043 shares and 47,502 shares, respectively, pursuant to the ESPP six-month purchase period ended February 26, 2024 and February 25, 2023, respectively. The Company used the Black-Scholes model to estimate the fair value of the purchase rights under the ESPP. For the thirteen weeks ended March 31, 2024, the Company utilized the following assumptions: | | | | | Expected term (in years) | | | 0.50 to 1.00 | | Expected volatility | | | 81.95 to 91.30 | % | Risk-free interest rate | | | 5.03 to 5.34 | % | Dividend yield | | | - | | Weighted average fair value per share of ESPP awards granted | | $ | 0.65 to 0.90 | |
2021 Equity Plan During April 2021, the Company’s Board of Directors adopted the 2021 Equity Plan. The 2021 Equity Plan provided for the issuance of incentive stock options, restricted stock, restricted stock units and other stock-based and cash-based awards to the Company’s employees, directors, and consultants. The maximum aggregate number of shares reserved for issuance under the 2021 Equity Plan was 925,000 shares. The options outstanding under the 2021 Equity Plan expire ten years from the date of grant. The Company issues new shares of common stock to satisfy stock option exercises. In connection with the closing of the IPO, no further awards will be granted under the 2021 Equity Plan. Former CEO Stock Options and Special Compensation Awards In April 2021, the Company entered into an Employment Agreement (the “McCreight IPO Employment Agreement”) with the former CEO, David McCreight, and granted stock options under the 2021 Equity Plan to purchase 322,793 shares of common stock with an exercise price of $11.35 per share, which vest based on service and performance conditions. 275,133 of these stock options have only service vesting conditions, and 47,660 of these stock options have both service and performance vesting conditions. In addition, a portion of these stock options were subject to accelerated vesting conditions upon the occurrence of certain future events, which were satisfied upon the closing of the IPO. As previously disclosed on a Form 8-K filed on February 13, 2023 (the “February 13 8-K”), Mr. McCreight voluntarily forfeited 161,396 unvested stock options of the Company. During the thirteen weeks ended April 2, 2023, the forfeiture of 161,396 unvested stock resulted in immediate acceleration of the remaining $1.2 million of compensation expense which was recorded to general and administrative expense. As previously disclosed in the February 13 8-K, the Company and David McCreight also entered into the First Amendment to Lulu’s Fashion Lounge Holdings, Inc. 2021 Equity Incentive Plan Stock Option Agreement that extends the post-termination exercise period of 161,397 vested stock options from 90 days to three (3) years from a termination of service other than for cause, death or disability. Under the McCreight IPO Employment Agreement and subject to ongoing employment, and in light of the closing of the IPO, the former CEO received two bonuses, each of which were settled in 208,914 fully-vested shares of the Company’s common stock. The Company recognized the final $0.4 million of equity-based compensation expense related to this award in the thirteen weeks ended April 2, 2023. Stock Options A summary of stock option activity is as follows (in thousands, except per share amounts and years): | | | | | | | | | | | | | | | Weighted- | | Weighted- | | | | | | | | Average | | Average | | | | | | | | Exercise | | Remaining | | Aggregate | | | Options | | Price per | | Contractual | | Intrinsic | | | Outstanding | | Option | | Life (years) | | Value | Balance as of December 31, 2023 | | 161,397 | | $ | 11.35 | | 7.29 | | | | Granted | | — | | | — | | — | | | | Forfeited | | — | | | — | | — | | | | Outstanding as of March 31, 2024 | | 161,397 | | $ | 11.35 | | 7.04 | | | | Exercisable as of March 31, 2024 | | 161,397 | | $ | 11.35 | | 7.04 | | $ | — | Vested and expected to vest as of March 31, 2024 | | 161,397 | | $ | 11.35 | | 7.04 | | $ | — |
Restricted Stock and Restricted Stock Units (“RSUs”) Immediately before the completion of the IPO, the LP was liquidated and the unit holders of the LP received shares of the Company’s common stock in exchange for their units of the LP. The Class P unit holders received 1,964,103 shares of common stock, comprised of 1,536,304 shares of vested common stock and 427,799 shares of unvested restricted stock. Any such shares of restricted stock received in respect of unvested Class P units of the LP are subject to vesting and a risk of forfeiture to the same extent as the corresponding Class P units. The Company recorded equity-based compensation expense of $0.1 million and $0.2 million during the thirteen weeks ended March 31, 2024, and April 2, 2023, respectively, related to the exchanged restricted stock. As of March 31, 2024, the unrecognized equity-based compensation expense for all restricted stock is $0.3 million and will be recognized over a weighted-average period of 0.58 years. The following table summarizes the rollforward of unvested restricted stock during the thirteen weeks ended March 31, 2024: | | | | | | | | Unvested | | Weighted- | | | Restricted | | Average Fair | | | Stock | | Value per Share | Balance at December 31, 2023 | | 23,379 | | $ | 4.54 | Restricted stock granted | | — | | | — | Restricted stock vested | | (6,727) | | | 4.41 | Restricted stock forfeited | | (1,035) | | | 4.54 | Balance at March 31, 2024 | | 15,617 | | $ | 4.17 |
During the thirteen weeks ended March 31, 2024, the Company entered into a second amendment to the employment agreement with Mark Vos, the President and Chief Information Officer (the “2024 President & CIO Employment Agreement”), under which 660,000 RSUs were initially granted, subject to various vesting schedules as set forth in the 2024 President & CIO Employment Agreement. On February 16, 2024, Tiffany Smith, the Chief Financial Officer received 175,000 RSUs pursuant to the applicable RSU Award Agreement, which vest over a three-year service period. On February 16, 2024, Laura Deady, the Chief Merchandising Officer, received 152,273 RSUs pursuant to her employment agreement entered into in December 2023 (“2024 CMO Employment Agreement”) and the applicable RSU Award Agreement, which vest over a three-year service period. During the thirteen weeks ended March 31, 2024, the Company granted 1,914,071 RSUs to certain executives (inclusive of the aforementioned RSU grants to Mr. Vos, Ms. Deady and Ms. Smith), and employees which are subject to various vesting schedules as set forth in the applicable employment agreement or RSU Award Agreements. During the thirteen weeks ended March 31, 2024, the Company granted 26,616 RSUs to certain directors which vested immediately or pursuant to the Company’s Non-Employee Director Compensation Program. The Company recognized equity-based compensation expense of $1.6 million and $2.8 million during the thirteen weeks ended March 31, 2024, and April 2, 2023, respectively, related to the RSUs. As of March 31, 2024, the unrecognized equity-based compensation expense is $11.3 million and will be recognized over a weighted-average period of 2.30 years. The following table summarizes the roll forward of unvested RSUs during the thirteen weeks ended March 31, 2024: | | | | | | | | | | Weighted- | | | Unvested | | Average Fair | | | RSUs | | Value per Share | Balance at December 31, 2023 | | 3,568,406 | | $ | 3.14 | RSUs granted | | 1,940,687 | | | 2.03 | RSUs vested | | (983,460) | | | 2.71 | RSUs forfeited | | (72,153) | | | 2.71 | Balance at March 31, 2024 | | 4,453,480 | | $ | 2.76 |
Performance Stock Units (“PSUs”) Under Crystal Landsem’s 2023 employment agreement (“the CEO Employment Agreement”), Ms. Landsem received a grant of 1,811,571 PSUs on March 5, 2023 which vest in three equal annual installments of 603,857 PSUs subject to the achievement of trailing ten day volume-weighted average price targets of the Company’s common stock and her continued employment on the vesting dates. Under the 2024 President & CIO Employment Agreement, Mr. Vos received a grant of 300,000 PSUs on January 9, 2024 which vest subject to the achievement of trailing ten day volume-weighted average price targets of the Company’s common stock and his continued employment on the vesting dates. Under the 2024 CMO Employment Agreement, Ms. Deady received a grant of 50,000 PSUs on February 16, 2024, which vest subject to the achievement of specified Company trailing twelve month net revenue growth targets and her continued employment on the vesting dates. The Company recognized equity-based compensation expense of $0.6 million and $0.2 million during the thirteen weeks ended March 31, 2024, and April 2, 2023, respectively, related to the PSUs. As of March 31, 2024, the unrecognized equity-based compensation expense is $2.1 million for the financial milestones that were considered probable of achievement, which will be recognized over a weighted-average period of 1.71 years. The following table summarizes the rollforward of unvested PSUs during the thirteen weeks ended March 31, 2024: | | | | | | | | | | Weighted- | | | Unvested | | Average Fair | | | PSUs | | Value per Share | Balance at December 31, 2023 | | 1,811,571 | | $ | 2.65 | PSUs granted | | 350,000 | | | 1.81 | PSUs vested | | — | | | — | PSUs forfeited | | — | | | — | Balance at March 31, 2024 | | 2,161,571 | | $ | 2.51 |
|